Mahamaya Lifesciences Ltd EPS

Mahamaya Lifesciences Ltd EPS

Image

Mahamaya Lifesciences Ltd

NSE: MAHALIFE

EPS

₹ 7.06

Last updated on: Jul 29, 2026

Key Highlights

  • The Earning per Share of Mahamaya Lifesciences Ltd is ₹ 7.06 as of 29 Jul 26 The earning per share of Mahamaya Lifesciences Ltd changed from ₹ 3.04 to ₹ 3.04 over 1 quarters. This represents a CAGR of 0.00% .

Historical Earning per Share of Mahamaya Lifesciences Ltd

No data available

* All values are in

Company Fundamentals for Mahamaya Lifesciences Ltd

Market Cap

393 Cr

EPS

7.1

P/E Ratio (TTM)

23.8

P/B Ratio (TTM)

3.2

Day’s High

168.7

Day’s Low

164.0

DTE

0.7

ROE

13.6

52 Week High

205.05

52 Week Low

111.0

ROCE

15.1

Market Price of Mahamaya Lifesciences Ltd

1M

1Y

3Y

5Y

Monitoring Mahamaya Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
29 Jul 2026168
28 Jul 2026165.1
27 Jul 2026165.5
24 Jul 2026166
23 Jul 2026165.65
21 Jul 2026172
20 Jul 2026171.55
17 Jul 2026163
16 Jul 2026164.9
15 Jul 2026165.8

BlinkX Score for Mahamaya Lifesciences Ltd

Asset Value vs Market Value of Mahamaya Lifesciences Ltd

Market Value

393

Asset Value

Value addition

1.5 X

157

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Mahamaya Lifesciences Ltd393.2
UPL Ltd51440
P I Industries Ltd41767
Sumitomo Chemical India Ltd25057
Bayer CropScience Ltd19046
Sharda Cropchem Ltd7444

Historical Market Cap of Mahamaya Lifesciences Ltd

No data available

* All values are in crore

Historical Revenue of Mahamaya Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of Mahamaya Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of Mahamaya Lifesciences Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Mahamaya Lifesciences Ltd News Hub

Shares of Mahamaya Lifesciences list in MT Group

The equity shares of Mahamaya Lifesciences (Scrip Code: 544611) are listed effective 18 November 202

Read more

18 Nov 25

BSE SME Mahamaya Lifesciences debuts with a modest pulse

The scrip was listed at Rs 116, a premium of 1.75% over the initial public offer (IPO) price. The st

Read more

18 Nov 25

Mahamaya Lifesciences to announce Quarterly Result

Mahamaya Lifesciences will hold a meeting of the Board of Directors of the Company on 2 December 202

Read more

27 Nov 25

Mahamaya Lifesciences to hold board meeting

Mahamaya Lifesciences will hold a meeting of the Board of Directors of the Company on 25 May 2026.

Read more

22 May 26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Mahamaya Lifesciences Ltd

What is the EPS of Mahamaya Lifesciences Ltd stock?

The Earnings Per Share (EPS) of Mahamaya Lifesciences Ltd is 7.06. An EPS is the amount of net income attributed to each share of a common stock.

How is Mahamaya Lifesciences Ltd EPS calculated?

The EPS of Mahamaya Lifesciences Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Mahamaya Lifesciences Ltd report its EPS?

Mahamaya Lifesciences Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Mahamaya Lifesciences Ltd EPS?

Factors that influence the EPS of Mahamaya Lifesciences Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Mahamaya Lifesciences Ltd EPS growth indicate future performance?

Yes, consistent growth in Mahamaya Lifesciences Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions